A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
Phase 1 Completed
23 enrolled
UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
Phase 2 Completed
15 enrolled 15 charts
METZOLIMOS
Phase 1 Completed
23 enrolled 15 charts
SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors
Phase 2 Completed
21 enrolled
A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis
Phase 1/2 Completed
9 enrolled 5 charts
Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma
Phase 2 Completed
70 enrolled
Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
Phase 1/2 Completed
36 enrolled 15 charts
Sirolimus in Treating Patients With Glioblastoma Multiforme
Phase 1/2 Completed
13 enrolled
Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma
Phase 1 Completed
19 enrolled
Aflac ST0901
Phase 1 Completed
18 enrolled
Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
Phase 2 Completed
210 enrolled 15 charts
SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors)
Phase 1/2 Completed
20 enrolled 20 charts
Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma
Phase 2 Completed
46 enrolled 13 charts
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
Phase 1/2 Completed
115 enrolled 13 charts
Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Phase 1/2 Completed
92 enrolled 24 charts
Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas
Phase 2 Completed
60 enrolled 31 charts
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
Phase 2 Completed
87 enrolled 11 charts
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
Phase 1 Completed
18 enrolled
Gemcitabine Plus Rapamycin Versus Gemcitabine to Treat Advanced Soft Tissue Sarcoma
Phase 1/2 Completed
28 enrolled
Selumetinib With or Without Temsirolimus in Treating Patients With Metastatic, Recurrent, or Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed By Surgery
Phase 2 Completed
70 enrolled 8 charts
OCR
Phase 2 Completed
49 enrolled 7 charts
Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma
Phase 2 Completed
178 enrolled 6 charts
Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
Phase 1/2 Completed
69 enrolled 12 charts
GEIS-29
Phase 2 Completed
33 enrolled
Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma
Phase 1 Completed
7 enrolled
Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme
Phase 2 Completed
32 enrolled 13 charts
CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme
Phase 2 Completed
33 enrolled
CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor
Phase 2 Completed
55 enrolled
Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 1 Completed
56 enrolled
Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation
Phase 1/2 Completed